PWM
VBIV icon

Perigon Wealth Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Perigon Wealth Management’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-17
Closed -$2K – 764
2016
Q3 		$2K Buy
+17
New +$1.91K ﹤0.01% 607

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
TFCP
Twin Focus Capital Partners Boston, Massachusetts $983M AUM 37.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Perigon Wealth Management's VBIV Position: Q4 2016 in Review

Perigon Wealth Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2016, closing a stake of 17 shares — an estimated $2K sold.

Perigon Wealth Management first reported a position in VBIV in Q3 2016 and held it in 1 quarter. The position peaked at $2K in Q3 2016. 21 funds tracked by Wall St. Rank hold VBIV as of Q4 2016.

  • Perigon Wealth Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2016 after selling out during the quarter.
  • Perigon Wealth Management sold 17 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2016, an estimated $2K.
  • Perigon Wealth Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2016 and held it in 1 quarter.
  • Perigon Wealth Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $2K in Q3 2016.
  • 21 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2016.

Based on Perigon Wealth Management's 13F filing for Q4 2016, filed 7 Mar 2017.